Tom Cole
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Virology top 5%
- HIV Research and Treatment
Papers in
- Virology 9
- HIV Research and Treatment 9
-
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Robin J. Shattock (7 shared papers)Leon R. McFarlane (3 shared papers)Suzanne Day (3 shared papers)Hannah M. Cheeseman (3 shared papers)Max Per Kristiansen (1 shared paper)Helene Bæk Juel (1 shared paper)Karen Smith Korsholm (1 shared paper)Morten Rühwald (1 shared paper)
- Journals
- Vaccine (3 papers)Frontiers in Immunology (2 papers)PLoS ONE (2 papers)EClinicalMedicine (2 papers)EBioMedicine (2 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Tom Cole
19 papers receiving 2.7k citations
Tom Cole's Hit Papers
Peers
Comparison fields: 5 of 106
- Infectious Diseases 1.7k
- Virology 152
- Biotechnology 175
- Microbiology 123
- Immunology 190
Countries citing papers authored by Tom Cole
This map shows the geographic impact of Tom Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Cole more than expected).
Fields of papers citing papers by Tom Cole
This network shows the impact of papers produced by Tom Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Cole. The network helps show where Tom Cole may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Cole, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Hit paper breakdown → | 2020 | 1939 |
| 2 | 2015 | 205 | |
| 3 | 2019 | 160 | |
| 4 | 2021 | 145 | |
| 5 | 2021 | 70 | |
| 6 | 2011 | 46 | |
| 7 | 2010 | 38 | |
| 8 | 2022 | 37 | |
| 9 | 2016 | 31 | |
| 10 | 2010 | 29 | |
| 11 | 2024 | 26 | |
| 12 | 2011 | 23 | |
| 13 | 2022 | 23 | |
| 14 | 2017 | 17 | |
| 15 | 2022 | 17 | |
| 16 | 2019 | 14 | |
| 17 | 2018 | 10 | |
| 18 | 2022 | 9 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 0 |
About Tom Cole
Tom Cole is a scholar working on Virology, Infectious Diseases, Microbiology, Biotechnology and Pharmaceutical Science, having authored 20 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (9 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Reproductive tract infections research (2 papers), Bacterial Infections and Vaccines (1 paper), Advanced Drug Delivery Systems (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Influenza Virus Research Studies (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (152 citations), Biotechnology (175 citations), Microbiology (123 citations) and Immunology (190 citations). Tom Cole has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Robin J. Shattock, Leon R. McFarlane, Suzanne Day, Hannah M. Cheeseman, Max Per Kristiansen, Helene Bæk Juel, Karen Smith Korsholm, Morten Rühwald, Sonya Abraham and Peter Fibiger Bang. Their work appears in journals such as Vaccine, Frontiers in Immunology, PLoS ONE, EClinicalMedicine and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.